Literature DB >> 35767206

Quantitative assessment of fibrosis-4 score and adverse clinical outcomes in patients with COVID-19.

Kefu Tang1, Lu Wang2, Lu Shen2, Lin He3, Xi Wu4.   

Abstract

Entities:  

Year:  2022        PMID： 35767206      PMCID： PMC9244247          DOI： 10.1007/s11427-021-2138-7

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN： 1674-7305            Impact factor:   10.372


× No keyword cloud information.
  10 in total

1.  Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores.

Authors:  Giovanni Targher; Alessandro Mantovani; Christopher D Byrne; Xiao-Bo Wang; Hua-Dong Yan; Qing-Feng Sun; Ke-Hua Pan; Kenneth I Zheng; Yong-Ping Chen; Mohammed Eslam; Jacob George; Ming-Hua Zheng
Journal:  Gut       Date:  2020-05-15       Impact factor: 23.059

2.  Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population.

Authors:  Isabel Graupera; Maja Thiele; Miquel Serra-Burriel; Llorenç Caballeria; Dominique Roulot; Grace Lai-Hung Wong; Núria Fabrellas; Indra Neil Guha; Anita Arslanow; Carmen Expósito; Rosario Hernández; Guruprasad Padur Aithal; Peter R Galle; Guillem Pera; Vincent Wai-Sun Wong; Frank Lammert; Pere Ginès; Laurent Castera; Aleksander Krag
Journal:  Clin Gastroenterol Hepatol       Date:  2021-12-29       Impact factor: 11.382

3.  Mendelian Randomization Analysis Reveals No Causal Relationship Between Nonalcoholic Fatty Liver Disease and Severe COVID-19.

Authors:  Jiuling Li; Aowen Tian; Haoxue Zhu; Lanlan Chen; Jianping Wen; Wanqing Liu; Peng Chen
Journal:  Clin Gastroenterol Hepatol       Date:  2022-02-03       Impact factor: 13.576

4.  SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.

Authors:  Yijin Wang; Shuhong Liu; Hongyang Liu; Wei Li; Fang Lin; Lina Jiang; Xi Li; Pengfei Xu; Lixin Zhang; Lihua Zhao; Yun Cao; Jiarui Kang; Jianfa Yang; Ling Li; Xiaoyan Liu; Yan Li; Ruifang Nie; Jinsong Mu; Fengmin Lu; Shousong Zhao; Jiangyang Lu; Jingmin Zhao
Journal:  J Hepatol       Date:  2020-05-11       Impact factor: 25.083

5.  COVID-19 and liver injury: a meta-analysis.

Authors:  Karn Wijarnpreecha; Patompong Ungprasert; Panadeekarn Panjawatanan; Denise M Harnois; Himesh B Zaver; Aijaz Ahmed; Donghee Kim
Journal:  Eur J Gastroenterol Hepatol       Date:  2021-07-01       Impact factor: 2.566

6.  Liver Injury and Elevated FIB-4 Define a High-Risk Group in Patients with COVID-19.

Authors:  Dana Crisan; Lucretia Avram; Cristiana Grapa; Alexandra Dragan; Dan Radulescu; Sorin Crisan; Alin Grosu; Valentin Militaru; Elena Buzdugan; Laurentiu Stoicescu; Liliana Radulescu; Felix Ciovicescu; Delia Bunea Jivanescu; Oana Mocan; Bogdan Micu; Valer Donca; Luminita Marinescu; Antonia Macarie; Marina Rosu; Andrada Nemes; Rares Craciun
Journal:  J Clin Med       Date:  2021-12-28       Impact factor: 4.241

7.  Possible unrecognised liver injury is associated with mortality in critically ill COVID-19 patients.

Authors:  Mario Romero-Cristóbal; Ana Clemente-Sánchez; Patricia Piñeiro; Jamil Cedeño; Laura Rayón; Julia Del Río; Clara Ramos; Diego-Andrés Hernández; Miguel Cova; Aranzazu Caballero; Ignacio Garutti; Pablo García-Olivares; Javier Hortal; Jose-Eugenio Guerrero; Rita García; Rafael Bañares; Diego Rincón
Journal:  Therap Adv Gastroenterol       Date:  2021-06-14       Impact factor: 4.409

8.  COVID-19: Abnormal liver function tests.

Authors:  Qingxian Cai; Deliang Huang; Hong Yu; Zhibin Zhu; Zhang Xia; Yinan Su; Zhiwei Li; Guangde Zhou; Jizhou Gou; Jiuxin Qu; Yan Sun; Yingxia Liu; Qing He; Jun Chen; Lei Liu; Lin Xu
Journal:  J Hepatol       Date:  2020-04-13       Impact factor: 25.083
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.